Premium
Diclofenac sodium and occlusal splint therapy in TMJ osteoarthritis: a randomized controlled trial
Author(s) -
MEJERSJÖ C.,
WENNEBERG B.
Publication year - 2008
Publication title -
journal of oral rehabilitation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.991
H-Index - 93
eISSN - 1365-2842
pISSN - 0305-182X
DOI - 10.1111/j.1365-2842.2008.01863.x
Subject(s) - medicine , diclofenac sodium , osteoarthritis , diclofenac , splint (medicine) , temporomandibular joint , randomized controlled trial , adverse effect , dentistry , surgery , anesthesia , physical therapy , alternative medicine , pathology , pharmacology
Summary The aim of the study was to compare treatment with diclofenac sodium (Voltaren 3 × 50 mg) to occlusal splint therapy in a randomized, single‐blind controlled trial of patients with a diagnosis of temporomandibular joint (TMJ) osteoarthritis (OA) in accordance with Research Diagnostic Criteria for temporomandibular disorders. Patients with general joint disorders or restrictions against medication with non‐steroidal anti‐inflammatory drug were not included. Twenty‐seven females and two males (aged 36–76 years) included, answered a standardized questionnaire and were clinically examined and they underwent TMJ tomography. The treatment was randomized to either splint ( n = 15) or diclofenac ( n = 14). The temperatures over the TMJs were determined. The patients were re‐examined 1 week, 1 month and 3 months after the start of treatment. A 1‐year follow‐up was carried out using questionnaires. After 1 week of treatment with diclofenac, significant reductions of pain and discomfort, TMJ tenderness and joint pain on jaw movements were noted. The splint therapy gave a significant reduction of reported symptoms after 1 month of treatment. Both treatments gave few adverse effects and were on an equal level. Estimation of the degree of inflammation by measuring the surface temperature over the TMJ was not reliable. Structural changes of the symptomatic TMJs were radiographically found in 82%, the contralateral, symptom‐free TMJ had changes in 36%. There was a discrepancy between the clinical and the radiographical findings. Diclofenac gave a more rapid improvement, but both treatments gave a significant reduction of symptoms of TMJ OA within 3 months which remained at the one‐year follow‐up .